REGULATORY

FRI, JUL 17, 2020 09:00 CET

RLS GLOBAL AB (publ) INTERIM REPORT, Q2, 2020

APRIL 1st – JUNE 30th
  • Net sales amounted to TSEK 739 (TSEK 464)
  • Earnings before interest and taxes (EBIT) amounted to MSEK -5,6 (MSEK -5,8)
  • Earnings per share before dilution at SEK -0,09 (SEK-0,02)
  • Cash flow from operating activities amounted to MSEK -5,5 (MSEK-6,3)
  • Liquid assets at the end of the period MSEK 30,3 (MSEK 8,3)
  • Equity ratio was 91 % (82 %)
JANUARY 1st – JUNE 30th
  • Net sales amounted to MSEK 1,1 (MSEK 0,7)
  • Earnings before interest and taxes (EBIT) amounted to MSEK -9,5 (MSEK-11,6)
  • Earnings per share before dilution at SEK -0,14 (SEK -0,20)
  • Cash flow from operating activities amounted to MSEK -10,9 (MSEK -11,8)
  • Liquid assets at the end of the period MSEK 30,3 (MSEK 8,3)
  • Equity ratio was 91 % (82 %)
SUMMARY OF EVENTS DURING SECOND QUARTER
  • AGM was held on May 26
  • RLS Global AB has signed an agreement with Region Stockholm and Gotland for ChloraSolv
  • A successful launch in the Region of Kalmar – RLS now see that the purchase of ChloraSolv reappears with several users
  • RLS has established a collaboration with Cardiff University UK and Bispebjerg Hospital Denmark and tests will start in August / September
SUMMARY OF EVENTS AFTER SECOND QUARTER
  • The ChloraSolv01 study is closed, the first results have been received by RLS. Scientific report will be

compiled by chief examiner Jan Apelqvist

COVID-19
  • In the current situation, the Board has considered the impact of different possible future COVID-19 related scenarios
  • Because the healthcare sector is so extremely strained under the prevailing circumstances, all processes take longer which affects our market penetration and other activities, resulting in RLS focusing even more on R&D projects
  • There is an increased interest in CariSolv due to the result of the transition in the dental industry from procedures that generate aerosol to chemo-mechanical treatments
Trading place and Certified Advisor

RLS Global’s shares has been listed on the Nasdaq First North Growth Market since 17th May, 2017 and trading takes place under the short name RLS. Certified Advisor is Redeye Aktiebolag, phone: +46 8 121 576 90, email: certifiedadviser@redeye.se. During the period 2012 – 2017, the company was listed on Aktietorget.

Contact information

Karin Fischer, CEO
E-mail: karin.fischer@rlsglobal.se
Telephone: +46 702-48 46 51

Eva Jagenheim, CFO
E-mail: eva.jagenheim@rlsglobal.se
Telephone: +46 31 780 68 20

Publication

RLS Global AB (publ) is obliged to make the information contained herein public pursuant to the EU market abuse regulation. The information was submitted for publication through the agency of the above contact person, at 09.00 CET on July 17th, 2020.

RLS GLOBAL AB (publ) INTERIM REPORT, Q2, 2020